Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
PellePharm to Present at Cantor Fitzgerald Global Healthcare Conference
-
Rocket Pharmaceuticals Announces Participation at Upcoming Conferences
-
Sangamo Therapeutics Announces Participation At Upcoming Investor and Industry Conferences
-
Revance to Participate in the Cantor Fitzgerald 2018 Global Healthcare Conference
-
UNITY Biotechnology, Inc. to Participate in the Cantor Fitzgerald Annual Global Healthcare Conference
-
Opnet Technologies, Inc. (OPNT) to Offer Common Stock
-
Opiant Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Opiant Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
AnaptysBio (ANAB) PT Raised to $140 at Cantor Fitzgerald
-
Amarin Corporation (AMRN) PT Raised to $15 at Cantor Fitzgerald
-
Intellia Therapeutics to Present at October Healthcare Investor Conferences
-
Albireo to Present at Cantor Fitzgerald Global Healthcare Conference
-
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Bausch Health Announces Participation In Upcoming Investor Conferences
-
resTORbio to Present at 2018 Cantor Fitzgerald Global Healthcare Conference
-
resTORbio to Present at 2018 Cantor Fitzgerald Global Healthcare Conference
-
Calithera Biosciences to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference and the Leerink Partners Rare Disease & Oncology Roundtable
-
Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Amneal to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Corium to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Dicerna to Participate in Two Upcoming Investor Conferences
-
Corium to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Aerpio Pharmaceuticals to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
AxoGen, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Protagonist Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference Monday, Oct. 1
-
Pfenex to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Ur-Energy (URG) Prices 12.2M Share Common Offering at $0.82/Sh
-
Ur-Energy Inc. Announces Pricing of Public Offering of Common Shares and Warrants
-
CareDx to Participate in Upcoming Investor Conference
-
Cantor Fitzgerald Starts Zynerba Pharmaceuticals (ZYNE) at Overweight
-
Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Supernus to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
ContraFect to Present at Two Upcoming Investor Conferences
-
aTyr Pharma to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference
-
Ur-Energy (URG) Announces Proposed Common Share & Warrants Offering
-
Cantor Fitzgerald Starts Cara Therapeutics (CARA) at Overweight
-
Ur-Energy Inc. Announces Proposed Public Offering of Common Shares and Warrants
-
Cantor Fitzgerald Starts Kalvista Pharmaceuticals Inc (KALV) at Overweight
-
Cantor Fitzgerald Starts electroCore Inc. (ECOR) at Overweight
-
Cantor Fitzgerald Starts Cytokinetics (CYTK) at Overweight
-
Cantor Fitzgerald Starts Catalyst Pharmaceutical Partners (CPRX) at Overweight
-
Cantor Fitzgerald Starts Adverum Biotechnologies (ADVM) at Overweight
-
Matthew McConaughey, Common, Liev Schreiber And Dozens Of Stars Shine A Light On Charities, Raising Millions Of Dollars At BGC Partners', Cantor Fitzgerald's Charity Day
-
Alec Baldwin, Goldie Hawn, Common, And Dozens Of Other Stars Align To Raise Millions Of Dollars At Cantor Fitzgerald's And BGC Partners' Charity Day
-
Catalyst Pharmaceuticals to Participate in Two Upcoming Investor Conferences

